Could NCOA5 a novel candidate gene for multiple sclerosis susceptibility?

Area of Science:

• Genetics
• Immunology
• Neurology

Background:

• Multiple sclerosis (MS) is an inflammatory, immune-mediated demyelinating disease with complex genetic and environmental factors.
• Nuclear cofactor genes are implicated in MS pathogenesis.
• NCOA5, a nuclear receptor coactivator, is involved in various diseases, including psoriasis, Behcet's disease, and cancer.

Purpose of the Study:

• To investigate the association between the NCOA5 gene polymorphism (rs2903908) and the risk of developing MS.
• To explore the potential role of NCOA5 in MS pathogenesis.

Main Methods:

• Genotyping of the NCOA5 rs2903908 polymorphism using RT-PCR.
• Analysis of genotype and allele frequencies in 157 MS patients and 160 healthy controls.

Main Results:

• The CC genotype and C allele of NCOA5 rs2903908 were significantly more frequent in MS patients compared to controls (p=0.0002 and p=0.003, respectively).
• Genotype frequencies: MS group (CC: 19.87%, CT: 37.82%, TT: 42.31%) vs. Control group (CC: 5.63%, CT: 43.75%, TT: 50.62%).

Conclusions:

• The CC genotype of NCOA5 rs2903908 is associated with an increased risk of MS (OR, 95% CI=4.16, 1.91-9.05).
• The C allele may recessively predispose individuals to MS.
• This study provides the first evidence suggesting NCOA5 gene's involvement in MS occurrence through potential molecular pathways.